Our results showed that almost equal amounts of ATF4 was increased by EPA and bortezomib, but only bortezomib potently decreased GSH, suggesting that ATF3 might play a more important role in inducing CHAC1 transcription in MM cells. The gene discussed is CHAC1; the disease is Miyoshi myopathy.